ATOSSA THERAPEUTICS, INC. - FORM S-1/A - EX-23.1 - EXHIBIT 23.1 - April 23, 2018

Attached files

file filename
EX-99.7 - EXHIBIT 99.7 - ATOSSA THERAPEUTICS, INC.s109744_ex99-7.htm
EX-99.6 - EXHIBIT 99.6 - ATOSSA THERAPEUTICS, INC.s109744_ex99-6.htm
EX-99.5 - EXHIBIT 99.5 - ATOSSA THERAPEUTICS, INC.s109744_ex99-5.htm
EX-99.4 - EXHIBIT 99.4 - ATOSSA THERAPEUTICS, INC.s109744_ex99-4.htm
EX-99.3 - EXHIBIT 99.3 - ATOSSA THERAPEUTICS, INC.s109744_ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - ATOSSA THERAPEUTICS, INC.s109744_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - ATOSSA THERAPEUTICS, INC.s109744_ex99-1.htm
EX-8.1 - EXHIBIT 8.1 - ATOSSA THERAPEUTICS, INC.s109744_ex8-1.htm
EX-5.1 - EXHIBIT 5.1 - ATOSSA THERAPEUTICS, INC.s109744_ex5-1.htm
EX-4.4 - EXHIBIT 4.4 - ATOSSA THERAPEUTICS, INC.s109744_ex4-4.htm
EX-4.3 - EXHIBIT 4.3 - ATOSSA THERAPEUTICS, INC.s109744_ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - ATOSSA THERAPEUTICS, INC.s109744_ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - ATOSSA THERAPEUTICS, INC.s109744_ex4-1.htm
EX-1.1 - EXHIBIT 1.1 - ATOSSA THERAPEUTICS, INC.s109744_ex1-1.htm
S-1/A - FORM S-1 - ATOSSA THERAPEUTICS, INC.s109744_s-1.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

Atossa Genetics Inc.
Seattle, Washington

 

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Amendment No. 1 to Registration Statement on Form S-1 of our report dated March 8, 2018, relating to the consolidated financial statements of Atossa Genetics Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

/s/ BDO USA, LLP
Seattle, Washington

 

April 23, 2018

 

 

ATOSSA THERAPEUTICS, INC. Reports